| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Shubhangi R Parkar, Seethalakshmi Ramanathan, Narendra Nair, Shefali A Batra, Shilpa A Adarkar, Purushottam Kund, Nawab Singh Baghel, S H Mogh. Are the effects of cannabis dependence on glucose metabolism similar to schizophrenia? An FDG PET understanding. Indian journal of psychiatry. vol 53. issue 1. 2011-07-14. PMID:21431002. |
are the effects of cannabis dependence on glucose metabolism similar to schizophrenia? |
2011-07-14 |
2023-08-12 |
Not clear |
| Shubhangi R Parkar, Seethalakshmi Ramanathan, Narendra Nair, Shefali A Batra, Shilpa A Adarkar, Purushottam Kund, Nawab Singh Baghel, S H Mogh. Are the effects of cannabis dependence on glucose metabolism similar to schizophrenia? An FDG PET understanding. Indian journal of psychiatry. vol 53. issue 1. 2011-07-14. PMID:21431002. |
cannabis has been associated with transient psychotic states; however, the causal relationship between cannabis and schizophrenia continues to remain a matter of debate. |
2011-07-14 |
2023-08-12 |
Not clear |
| Shubhangi R Parkar, Seethalakshmi Ramanathan, Narendra Nair, Shefali A Batra, Shilpa A Adarkar, Purushottam Kund, Nawab Singh Baghel, S H Mogh. Are the effects of cannabis dependence on glucose metabolism similar to schizophrenia? An FDG PET understanding. Indian journal of psychiatry. vol 53. issue 1. 2011-07-14. PMID:21431002. |
epidemiological and some biological studies hint at cannabis being an independent risk factor for schizophrenia; this has not been definitively proved. |
2011-07-14 |
2023-08-12 |
Not clear |
| D Basu, A Malhotra, V K Varm. Cannabis related psychiatric syndromes: a selective review. Indian journal of psychiatry. vol 36. issue 3. 2011-07-14. PMID:21743686. |
the controversial nature of the cannabis - schizophrenia link is noted, and various methodological issues in clinical cannabis research are highlighted. |
2011-07-14 |
2023-08-12 |
Not clear |
| Jeroen Decoster, Jim van Os, Gunter Kenis, Cecile Henquet, Joseph Peuskens, Marc De Hert, Ruud van Winke. Age at onset of psychotic disorder: cannabis, BDNF Val66Met, and sex-specific models of gene-environment interaction. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. vol 156B. issue 3. 2011-07-12. PMID:21305693. |
bdnf val66met and cannabis use before illness onset were retrospectively assessed in a sample of 585 patients with schizophrenia and their association with age at onset was evaluated. |
2011-07-12 |
2023-08-12 |
Not clear |
| Javier Costas, Julio Sanjuán, Ramón Ramos-Ríos, Eduardo Paz, Santiago Agra, Amparo Tolosa, Mario Páramo, Julio Brenlla, Manuel Arroj. Interaction between COMT haplotypes and cannabis in schizophrenia: a case-only study in two samples from Spain. Schizophrenia research. vol 127. issue 1-3. 2011-07-01. PMID:21310591. |
interaction between comt haplotypes and cannabis in schizophrenia: a case-only study in two samples from spain. |
2011-07-01 |
2023-08-12 |
human |
| Javier Costas, Julio Sanjuán, Ramón Ramos-Ríos, Eduardo Paz, Santiago Agra, Amparo Tolosa, Mario Páramo, Julio Brenlla, Manuel Arroj. Interaction between COMT haplotypes and cannabis in schizophrenia: a case-only study in two samples from Spain. Schizophrenia research. vol 127. issue 1-3. 2011-07-01. PMID:21310591. |
cannabis use is one of the environmental factors with more solid evidence contributing to schizophrenia risk, especially in genetically susceptible individuals. |
2011-07-01 |
2023-08-12 |
human |
| Javier Costas, Julio Sanjuán, Ramón Ramos-Ríos, Eduardo Paz, Santiago Agra, Amparo Tolosa, Mario Páramo, Julio Brenlla, Manuel Arroj. Interaction between COMT haplotypes and cannabis in schizophrenia: a case-only study in two samples from Spain. Schizophrenia research. vol 127. issue 1-3. 2011-07-01. PMID:21310591. |
the results of our study are discussed in the context of previous findings, suggesting the involvement of comt polymorphisms in the association between cannabis use and schizophrenia as well as the existence of additional factors mediating this association. |
2011-07-01 |
2023-08-12 |
human |
| Marc De Hert, Martien Wampers, Tihana Jendricko, Tomislav Franic, Domagoj Vidovic, Nele De Vriendt, Kim Sweers, Joseph Peuskens, Ruud van Winke. Effects of cannabis use on age at onset in schizophrenia and bipolar disorder. Schizophrenia research. vol 126. issue 1-3. 2011-06-24. PMID:20674280. |
effects of cannabis use on age at onset in schizophrenia and bipolar disorder. |
2011-06-24 |
2023-08-12 |
Not clear |
| Marc De Hert, Martien Wampers, Tihana Jendricko, Tomislav Franic, Domagoj Vidovic, Nele De Vriendt, Kim Sweers, Joseph Peuskens, Ruud van Winke. Effects of cannabis use on age at onset in schizophrenia and bipolar disorder. Schizophrenia research. vol 126. issue 1-3. 2011-06-24. PMID:20674280. |
cannabis use may decrease age at onset in both schizophrenia and bipolar disorder, given the evidence for substantial phenotypic and genetic overlap between both disorders. |
2011-06-24 |
2023-08-12 |
Not clear |
| Emanuel Schwarz, Phil Whitfield, Sven Nahnsen, Lan Wang, Hilary Major, F Markus Leweke, Dagmar Koethe, Pietro Lio, Sabine Bah. Alterations of primary fatty acid amides in serum of patients with severe mental illness. Frontiers in bioscience (Elite edition). vol 3. 2011-06-03. PMID:21196311. |
cannabis consumption is a well known risk factor for the onset of schizophrenia and evidence accumulates that the endocannabinoid system may play a central role in the disease etiology. |
2011-06-03 |
2023-08-12 |
human |
| Adverse effects of cannabis. Prescrire international. vol 20. issue 112. 2011-05-16. PMID:21462790. |
in australia, the marked increase in cannabis use has not been accompanied by an increased incidence of schizophrenia. |
2011-05-16 |
2023-08-12 |
Not clear |
| Daniel J Fridberg, Jennifer M Vollmer, Brian F O'Donnell, Patrick D Skosni. Cannabis users differ from non-users on measures of personality and schizotypy. Psychiatry research. vol 186. issue 1. 2011-05-12. PMID:20813412. |
accumulating evidence indicates that cannabis use may be a risk factor for schizophrenia (sz), and chronic cannabis users score higher than non-users on measures of schizotypal personality traits. |
2011-05-12 |
2023-08-12 |
Not clear |
| Jaime E C Hallak, Serdar M Dursun, Daniel C Bosi, Ligia Ribeiro Horta de Macedo, João Paulo Machado-de-Sousa, João Abrão, José A S Crippa, Phillip McGuire, John H Krystal, Glen B Baker, Antonio W Zuard. The interplay of cannabinoid and NMDA glutamate receptor systems in humans: preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects. Progress in neuro-psychopharmacology & biological psychiatry. vol 35. issue 1. 2011-05-03. PMID:21062637. |
cannabidiol (cbd), a cannabinoid-1/2 (cb1/2) receptor weak partial agonist or antagonist, may play a role in the treatment of schizophrenia. |
2011-05-03 |
2023-08-12 |
human |
| Zoltan Makkos, Lilla Fejes, Gabriella Inczédy-Farkas, Akos Kassai-Farkas, Gabor Faludi, Judit Lazar. Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency. Progress in neuro-psychopharmacology & biological psychiatry. vol 35. issue 1. 2011-05-03. PMID:21087649. |
although incidence of schizophrenia is higher among cannabis users and marijuana is the most common abused drug by adolescents, etiological linkage between schizophrenia and cannabis use is still not clarified. |
2011-05-03 |
2023-08-12 |
Not clear |
| Zoltan Makkos, Lilla Fejes, Gabriella Inczédy-Farkas, Akos Kassai-Farkas, Gabor Faludi, Judit Lazar. Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency. Progress in neuro-psychopharmacology & biological psychiatry. vol 35. issue 1. 2011-05-03. PMID:21087649. |
clinical experiences suggest that regular cannabis user can show similar psychotic episode to schizophrenic disorders but it is still unclear if chronic cannabis use with schizophreniform disorder is a distinct entity requiring special therapy or it can be treated as classical schizophrenia. |
2011-05-03 |
2023-08-12 |
Not clear |
| José Manuel Rodríguez-Sánchez, Rosa Ayesa-Arriola, Ignacio Mata, Teresa Moreno-Calle, Rocío Perez-Iglesias, César González-Blanch, José Antonio Periañez, José Luis Vazquez-Barquero, Benedicto Crespo-Facorr. Cannabis use and cognitive functioning in first-episode schizophrenia patients. Schizophrenia research. vol 124. issue 1-3. 2011-04-19. PMID:20826079. |
cannabis use and cognitive functioning in first-episode schizophrenia patients. |
2011-04-19 |
2023-08-12 |
Not clear |
| José Manuel Rodríguez-Sánchez, Rosa Ayesa-Arriola, Ignacio Mata, Teresa Moreno-Calle, Rocío Perez-Iglesias, César González-Blanch, José Antonio Periañez, José Luis Vazquez-Barquero, Benedicto Crespo-Facorr. Cannabis use and cognitive functioning in first-episode schizophrenia patients. Schizophrenia research. vol 124. issue 1-3. 2011-04-19. PMID:20826079. |
research into the effect of cannabis use in schizophrenia has yielded contradictory findings. |
2011-04-19 |
2023-08-12 |
Not clear |
| José Manuel Rodríguez-Sánchez, Rosa Ayesa-Arriola, Ignacio Mata, Teresa Moreno-Calle, Rocío Perez-Iglesias, César González-Blanch, José Antonio Periañez, José Luis Vazquez-Barquero, Benedicto Crespo-Facorr. Cannabis use and cognitive functioning in first-episode schizophrenia patients. Schizophrenia research. vol 124. issue 1-3. 2011-04-19. PMID:20826079. |
our aim has been to explore the correlates of cannabis use in cognitive and psychopathological features, both cross-sectional and longitudinally, in early phases of schizophrenia. |
2011-04-19 |
2023-08-12 |
Not clear |
| José Manuel Rodríguez-Sánchez, Rosa Ayesa-Arriola, Ignacio Mata, Teresa Moreno-Calle, Rocío Perez-Iglesias, César González-Blanch, José Antonio Periañez, José Luis Vazquez-Barquero, Benedicto Crespo-Facorr. Cannabis use and cognitive functioning in first-episode schizophrenia patients. Schizophrenia research. vol 124. issue 1-3. 2011-04-19. PMID:20826079. |
the use of cannabis does not seem to be associated with a negative effect on cognition in a representative sample of first-episode schizophrenia patients. |
2011-04-19 |
2023-08-12 |
Not clear |